NEW YORK, Nov. 14, 2016 -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Pattern Energy Group Inc. (“Pattern Energy” or the “Company”) (NASDAQ:PEGI) of the January 10, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
The lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of all those who purchased common shares of Pattern Energy between May 9, 2016 and November 4, 2016 (the “Class Period”). The case, Walsh v. Pattern Energy Group, Inc. et al, No. 3:16-cv-06560 was filed on November 11, 2016.
The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (i) Pattern Energy’s operations were deficient with respect to various transactions, process level, and monitoring controls; (ii) as a result, the Company lacked effective internal financial controls; and (iii) as a result, Pattern Energy’s public statements were materially false and misleading.
Specifically, on November 7, 2016, Pattern Energy announced its results for the quarter ended September 30, 2016. The Company disclosed a material weakness in internal controls over financial reporting.
On this news, Pattern Energy’s share price fell from $21.62 per share on November 4, 2016 to a closing price of $20.86 on November 7, 2016 —a $0.76 or a 3.52% drop.
Request more information now by clicking here: www.faruqilaw.com/PEGI. There is no cost or obligation to you.
Take Action
If you invested in Pattern Energy common stock or options between May 9, 2016 and November 4, 2016 and would like to discuss your legal rights, visit www.faruqilaw.com/PEGI. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Pattern Energy’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class that is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
FARUQI & FARUQI, LLP 685 Third Avenue, 26th Floor New York, NY 10017 Attn: Richard Gonnello, Esq. [email protected] Telephone: (877) 247-4292 or (212) 983-9330


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Anta Sports Expands Global Footprint With Strategic Puma Stake
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



